Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 6,677 | 903 | 207 | 8,083 | 6,011 |
| Gross Profit | 6,677 | 903 | 207 | 8,083 | 6,011 |
| Operating Expenses | 59,132 | 65,925 | 63,991 | 42,753 | 31,315 |
| Operating Income | -52,455 | -65,022 | -63,784 | -34,670 | -25,304 |
| Interest Expense | 1,519 | 1,494 | 1,206 | 1,253 | 948 |
| Other Income | -1,376 | 1,180 | -331 | -287 | 1,078 |
| Pre-tax Income | -55,350 | -65,336 | -65,321 | -36,210 | -25,174 |
| Net Income Continuous | -55,350 | -65,336 | -65,321 | -36,210 | -25,174 |
| Net Income | $-55,350 | $-65,336 | $-65,321 | $-36,210 | $-25,174 |
| EPS Basic Total Ops | -36.64 | -87.69 | -96.10 | -116.82 | -454.35 |
| EPS Basic Continuous Ops | -36.49 | -87.63 | -96.04 | -103.62 | -351.62 |
| EPS Diluted Total Ops | -36.64 | -87.69 | -96.10 | -116.82 | -454.35 |
| EPS Diluted Continuous Ops | -36.49 | -87.63 | -96.04 | -103.62 | -351.62 |
| EPS Diluted Before Non-Recurring Items | -36.64 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-51,883 | $-64,148 | $-62,801 | $-33,675 | $-24,260 |